| Literature DB >> 35745312 |
Turki D Alshehri1,2, Sunil Babu Kotha2,3, Faisal Mohammed Abed2,4, Mohammed J Barry2,5, Abdulrahman AlAsmari2,6, Sreekanth Kumar Mallineni7,8.
Abstract
This study aimed to compare the amount of fluoride uptake and the recharge and release characteristics of conventional glass ionomer cement (GIC) without any additives in comparison to conventional glass ionomer cement supplemented with silver nanoparticles (AgNPs) at two concentrations: 0.1% and 0.2% (w/w). A total of 60 specimens were used in this in vitro study. The sample was divided into six groups-including three groups without fluoride charge: Group 1 (conventional GIC), Group 2 (GIC with 0.1% silver nanoparticles), and Group 3 (GIC with 0.2% silver nanoparticles; and three groups with fluoride charge: Group 4 (conventional GIC with fluoride); Group 5 (GIC with 0.1% silver nanoparticles with fluoride); Group 6 (GIC with 0.2% silver nanoparticles with fluoride), where Group 1 is considered the control group and the other five groups are used as the test groups. The amount of fluoride released was measured on days 1, 2, 7, 15, and 30. The comparisons were made between the groups with and without fluoride and among all the groups. A significant difference in the amount of fluoride released was observed between the groups, with the highest amount occurring in Group 1, followed by Group 2; the lowest amount of fluoride released was observed in Group 3 (p < 0.05). The groups with fluoride recharge (Groups 4, 5, and 6) exhibited a higher amount of fluoride release than the groups with no recharge (Groups 1, 2, and 3); however, Group 1 has more fluoride release compared to all other groups on days 1, 2, 7, 15, and 30 (p < 0.05). The amount of released fluoride decreased from day 1 to day 30 in all of the groups in the study. Despite the antimicrobial and anticariogenic benefits of adding silver nanoparticles to GIC, it seems that fluoride release characteristics are significantly affected by the addition of this material. This may force the clinician to a compromise between the antimicrobial benefit of silver nanoparticles and the remineralizing advantage of fluoride.Entities:
Keywords: fluoride; glass ionomer cement; silver nanoparticles
Year: 2022 PMID: 35745312 PMCID: PMC9228982 DOI: 10.3390/nano12121971
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1Mean values of fluoride release in (a) Group 1 (control group with no recharge); (b) Group 2 (0.1% silver nanoparticles with no recharge); (c) Group 3 (0.2% silver nanoparticles with no recharge); (d) Group 4 (control group with fluoride recharge); (e) Group 5 (0.1% silver nanoparticles with fluoride recharge); and (f) Group 6 (0.2% silver nanoparticles with fluoride recharge) on days 1, 2, 7, 15, and 30.
Figure 2Pattern of fluoride release from the three groups at different time intervals without fluoride recharge.
Figure 3Pattern of fluoride release from the three groups at different time intervals with fluoride recharge.
Comparison baseline and baseline groups with fluoride release.
| Time Period | Group 1 | Group 4 | Group 2 | Group 5 | Group 3 | Group 6 | |||
|---|---|---|---|---|---|---|---|---|---|
|
| 5.21 (3.75,6.71) | 4.12 (3.09,5.76) | 0.251 | 2.31 (1.28,3.10) | 1.87 (1.05,2.87) | 0.465 | 1.34 (0.88,2.79) | 1.27 (0.79,2.51) | 0.754 |
|
| 5.18 (3.77,6.70) | 4.09 (3.09,5.70) | 0.251 | 2.27 (1.26,3.12) | 1.84 (1.04,2.87) | 0.465 | 1.15 (0.85,2.38) | 1.07 (0.76,1.93) | 0.564 |
|
| 5.14 (3.71,6.70) | 4.10 (3.09,5.75) | 0.347 | 2.29 (1.33,3.06) | 1.89 (1.05,2.90) | 0.602 | 1.12 (0.85,2.38) | 1.04 (0.76,1.93) | 0.564 |
|
| 5.16 (3.74,6.69) | 4.12 (3.05,5.69) | 0.347 | 2.30 (1.25,3.07) | 1.85 (1.03,2.87) | 0.530 | 1.16 (0.85,2.37) | 1.02 (0.76,1.89) | 0.564 |
|
| 5.20 (3.77,6.72) | 4.08 (3.02,5.75) | 0.251 | 2.25 (1.31,3.07) | 1.79 (2.87,1.06) | 0.530 | 1.12 (0.85,1.97) | 1.05 (0.77,1.88) | 0.564 |
|
| 5.17 (3.75,6.71) | 4.10 (3.07,5.73) | 0.251 | 2.28 (1.29,3.09) | 1.85 (1.05,2.87) | 0.465 | 1.14 (0.85,2.30) | 1.05 (0.76,1.91) | 0.564 |
Comparison of all study groups using Kruskal–Wallis test.
| Time Period | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 | |
|---|---|---|---|---|---|---|---|
|
| 5.21 (3.75,6.71) | 2.31 (1.28,3.10) | 1.34 (0.88,2.79) | 4.12 (3.09,5.76) | 1.87 (1.05,2.87) | 1.27 (0.79,2.51) | 0.002 * |
|
| 5.18 (3.77,6.70) | 2.27 (1.26,3.12) | 1.15 (0.85,2.38) | 4.09 (3.09,5.70) | 1.84 (1.04,2.87) | 1.07 (0.77,1.93) | 0.001 * |
|
| 5.14 (3.71,6.70) | 2.29 (1.33,3.06) | 1.12 (0.85,2.38) | 4.10 (3.09,5.75) | 1.89 (1.05,2.90) | 1.04 (0.76,1.93) | 0.001 * |
|
| 5.16 (3.74,6.69) | 2.30 (1.25,3.07) | 1.16 (0.85,2.37) | 4.12 (3.05,5.69) | 1.85 (1.03,2.87) | 1.02 (0.76,1.89) | 0.002 * |
|
| 5.20 (3.77,6.72) | 2.25 (1.31,3.07) | 1.12 (0.86,1.97) | 4.08 (3.02,5.75) | 1.79 (1.06,2.87) | 1.05 (0.77,1.88) | 0.001 * |
|
| 5.17 (3.74, 6.71) | 2.28 (1.28,3.08) | 1.14 (0.85,2.30) | 4.10 (3.07,5.73) | 1.84 (1.05,2.87) | 1.05 (0.76,1.91) | 0.001 * |
* Significant.